Persistent negative symptoms in schizophrenia: an overview.
about
Antipsychotics for people with persistent negative symptoms of schizophreniaPrefrontal Cortex and Social Cognition in Mouse and ManProof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophreniaA placebo-controlled study of tropisetron added to risperidone for the treatment of negative symptoms in chronic and stable schizophreniaRepetitive transcranial magnetic stimulation (rTMS) for treating major depression and schizophrenia: a systematic review of recent meta-analysesWhat do we really know about blunted vocal affect and alogia? A meta-analysis of objective assessments.Contribution of nonprimate animal models in understanding the etiology of schizophrenia.[Concept and results of the German Research Network on Schizophrenia].Neurobiological background of negative symptoms.Technology to assess and support self-management in serious mental illness.Cognitive behavior therapy for people with schizophrenia.Cortical thinning in temporo-parietal junction (TPJ) in non-affective first-episode of psychosis patients with persistent negative symptomsPsychosocial treatments for negative symptoms in schizophrenia: current practices and future directions.Upward spirals of positive emotions counter downward spirals of negativity: insights from the broaden-and-build theory and affective neuroscience on the treatment of emotion dysfunctions and deficits in psychopathologyA Longitudinal Examination of the Moderating Effects of Symptoms on the Relationship between Functional Competence and Real World Functional Performance in Schizophrenia.Identifying persistent negative symptoms in first episode psychosis.Randomized clinical trial of cognitive behavioral social skills training for schizophrenia: improvement in functioning and experiential negative symptoms.Religion's effect on mental health in schizophrenia: examining the roles of meaning-making and seeking social support.Do negative symptoms of schizophrenia change over time? A meta-analysis of longitudinal data.Course of neurological soft signs in first-episode schizophrenia: Relationship with negative symptoms and cognitive performancesRasagiline in the Treatment of the Persistent Negative Symptoms of Schizophrenia.Are Negative Symptoms Dimensional or Categorical? Detection and Validation of Deficit Schizophrenia With Taxometric and Latent Variable Mixture Models.A randomized pilot study of MOtiVation and Enhancement (MOVE) Training for negative symptoms in schizophrenia.Schizophrenia symptom and functional correlates of anterior cingulate cortex activation to emotion stimuli: An fMRI investigation.Social affiliation and negative symptoms in schizophrenia: Examining the role of behavioral skills and subjective respondingAn fMRI study of visual attention and sensorimotor function before and after antipsychotic treatment in first-episode schizophreniaMotivational and Behavioral Activation as an Adjunct to Psychiatric Rehabilitation for Mild to Moderate Negative Symptoms in Individuals with Schizophrenia: A Proof-of-Concept Pilot Study.Thinking glutamatergically: changing concepts of schizophrenia based upon changing neurochemical models.Neurocognition and neuroimaging of persistent negative symptoms of schizophrenia.Asenapine, iloperidone and lurasidone: critical appraisal of the most recently approved pharmacotherapies for schizophrenia in adults.Management of schizophrenia: clinical experience with asenapine.Neurocognition: clinical and functional outcomes in schizophrenia.Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia.Dissecting negative symptoms in schizophrenia: opportunities for translation into new treatments.Pharmacological treatment of negative symptoms in schizophrenia.Confirmatory Factor Analysis of the French Version of the Anticipatory and Consummatory Interpersonal Pleasure ScaleTreatment for Negative Symptoms in Schizophrenia: A Comprehensive Review.A study on negative and depressive symptom prevalence in individuals at ultra-high risk for psychosis.Future-directed thinking in first-episode psychosis.Conceptualization and treatment of negative symptoms in schizophrenia.
P2860
Q24239929-C32826FE-BDC5-46F3-BF22-95D374710790Q26774748-DE0B10A8-FF38-45AF-8A5F-82E326DA4F24Q28240120-4E3CC4F7-E886-482B-A9A7-2888297D2B2DQ28287576-9D4B7613-08DA-46EC-8200-66B4BB0AFDADQ28290977-4C8F2475-1ADF-4967-B8B6-7D18196F6980Q30400036-C8B156F8-60C9-4919-8DC4-A6490DF2A472Q30474963-875D5B64-8A04-4752-8004-46FB28BA9A8DQ30489053-0DFC935C-A3D3-49AE-A601-3F59E41ACC97Q30913824-0F1AD767-EEEE-4DAB-97EE-2AEF09E26F67Q33450031-4012BFDD-F9B8-48CF-AFC5-B3C056DA8AA6Q33609395-71EFCE9C-2F94-4EC6-A130-B03C31B5BAC5Q33826006-49837902-F6A8-428A-ABB2-2AB3200F08EEQ33882729-221BE581-739A-4BB1-8447-E5117F163ABFQ34012269-B4D3C64C-1B11-4CD3-B79B-0DE9D6C4CF6AQ34245341-FCEA4BC4-DD2D-4A52-B278-459AF45C92F8Q34502745-7A40DD81-A531-44C7-B1DB-C01BE40E9527Q34572488-7EE61F80-AD90-4E66-AD9F-FA8FDA4692C1Q35154055-49DEDBCE-66FE-4EE4-A0DD-952FCAE71A2BQ35450483-B3D8C0E1-B94B-4DCC-AD01-7C20E4ABE47DQ35693485-5910AA18-C160-4EE5-8E87-7419E2D049D6Q35738987-825D49A8-B411-42A9-BEC0-DAD8E4F06839Q35738993-753B328A-EC44-49E9-AFDD-55318F84DC3AQ35794290-3E8ED4DD-263F-499F-AC93-B941540254A7Q36372529-357B16FC-582F-42F2-AB22-46EA58F7EDC3Q36602613-2DEEB187-D9AA-485E-B052-48DCB0D3F3C3Q37222824-36068E38-1670-4730-8F8D-3D201A2FD238Q37411272-E9C27D1F-98C7-4D68-925A-D67BD735B9CFQ37794502-CA45EBE6-556D-46B5-A273-A56F2750169DQ37975551-4A9C80BA-77CA-460B-B073-DE5E5A3FD36FQ38070179-CF5FEA0C-4379-4295-B0FE-585A67EC7BB2Q38093729-F5A87903-0F23-4BEF-BFFD-1A78D45037AFQ38180211-05D53B74-D542-446D-A036-D792D9EA12F6Q38268878-8A62B784-131C-40D6-86C9-9E6D6E7EB240Q38291334-5477B6DD-DEC8-491B-B408-EE8D921ACFA7Q38431333-725AE0A4-8638-4235-945F-A77EA4D17E27Q38626638-F1135859-AF58-4DB6-8730-8F263AE8A1FBQ38647035-F645274D-AD3A-445E-B9A9-6DD1383AD784Q38819011-5DB8C17E-9A82-4ED5-B3CD-3B69119D3DE0Q38948450-3BF7FEFE-A324-4F2A-8C71-E6DBC473E312Q39178474-6AD3235B-0BD1-4FCF-BB96-0B7942BF029E
P2860
Persistent negative symptoms in schizophrenia: an overview.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Persistent negative symptoms in schizophrenia: an overview.
@ast
Persistent negative symptoms in schizophrenia: an overview.
@en
type
label
Persistent negative symptoms in schizophrenia: an overview.
@ast
Persistent negative symptoms in schizophrenia: an overview.
@en
prefLabel
Persistent negative symptoms in schizophrenia: an overview.
@ast
Persistent negative symptoms in schizophrenia: an overview.
@en
P2860
P356
P1476
Persistent negative symptoms in schizophrenia: an overview.
@en
P2093
Robert W Buchanan
P2860
P304
P356
10.1093/SCHBUL/SBL057
P407
P577
2006-11-10T00:00:00Z